Notochordal cancer is a very rare cancer that grows from leftover cells near the spine or base of the skull. It often grows slowly, but it can still damage nearby nerves, bone, and other tissues over time. The early symptoms of notochordal cancer can include ongoing back, neck, or head pain, numbness, weakness, or trouble with bowel, bladder, vision, or swallowing, depending on where it starts. Many people first hear about notochordal cancer in adulthood, although it can occur at other ages, and the outlook varies with the tumor’s size, location, and whether it can be fully treated. Treatment usually involves surgery and radiation, sometimes with other cancer care, and not everyone will have the same experience.
How many people live with Notochordal cancer?
Based on Orphanet's estimate that chordoma, the usual medical name for notochordal cancer, affects about 1 to 9 people per 1 million, roughly 8,000 to 73,000 people may be living with it worldwide (Orphanet, 2024). Using that same rare-disease range, about 340 to 3,100 people may be living with it in the United States (Orphanet, 2024); the range is wide because very rare cancers are counted differently in different tracking systems and studies.
Overview
Notochordal cancerSymptoms
Notochordal cancer often causes pain where the tumor grows, usually in the skull base, spine, or tailbone. People with notochordal cancer may also notice headaches, double vision, numbness, weakness, or trouble with bowel or bladder control.
Outlook and prognosis
Notochordal cancer often grows slowly, but it can return after treatment and may press on nearby nerves, bone, or the spinal cord. Outlook depends a lot on where it starts, whether surgery removes it fully, and if it has spread.
Causes and risk factors
For notochordal cancer, the exact cause is usually unclear. Risk may rise from inherited gene changes or rare genetic conditions, while most cases happen sporadically. It is not clearly linked to lifestyle or everyday environmental exposures.
Genetic influences
Genetics matter mainly in the tumor itself, not as an inherited cause. Most notochordal cancer cases happen sporadically through DNA changes that develop over time, while inherited risk is rare.
Diagnosis
Notochordal cancer is usually diagnosed with imaging, often MRI and CT scans, to locate the tumor and assess nearby bone or nerves. Doctors then confirm the diagnosis with a biopsy, and lab testing helps rule out look-alike tumors.
Treatment and drugs
Notochordal cancer is usually treated with surgery to remove as much of the tumor as possible. Many living with notochordal cancer also need carefully targeted radiation. Drug treatment may be used if the cancer spreads or returns.
Symptoms
Symptoms of notochordal cancer often depend on where the tumor is growing, such as the base of the skull or along the spine. The changes are often subtle at first, blending into daily life until they become more noticeable. Pain is common, but some people first notice headaches, nerve problems, or changes with walking, bladder control, or swallowing. Because the early symptoms of notochordal cancer can overlap with more common back, neck, or sinus problems, diagnosis is sometimes delayed.
Deep, steady pain in the back, neck, or tailbone area is common in notochordal cancer. It may build slowly over time and can be worse with sitting, lying down, or certain movements.
When notochordal cancer grows near the base of the skull, headaches can happen more often and may not feel like your usual tension or sinus headache. Some people also feel pressure behind the eyes or deep in the face.
A tumor near the skull base can affect nearby nerves and cause double vision, blurred vision, or trouble moving the eyes normally. Some may also notice hearing changes, ringing in the ears, or facial numbness.
Some people with notochordal cancer notice hoarseness, slurred speech, choking on food, or a feeling that swallowing takes more effort. This can happen if the tumor presses on nerves that help control the throat and tongue.
How people usually first notice Notochordal cancer?
People usually first notice notochordal cancer because of symptoms that build slowly over time, often starting with deep, stubborn pain in the lower back, neck, or base of the skull that does not go away as expected. As the tumor grows and presses on nearby nerves or the spinal cord, many living with notochordal cancer may also notice headaches, double vision, trouble swallowing, numbness, weakness, or changes in bowel or bladder control, depending on where the tumor is located. Because these problems can look like more common spine or nerve conditions at first, the first signs of notochordal cancer are sometimes missed until imaging tests such as MRI reveal the cause.
Types of Notochordal cancer
Notochordal cancer is usually described by where it starts along the spine, and that location often shapes the symptoms people notice. In everyday care, the main types of notochordal cancer are skull base, spinal, and sacral forms. Symptoms don’t always look the same for everyone. For many living with notochordal cancer, the early symptoms of notochordal cancer can be vague at first, then become more noticeable as the tumor grows and presses on nearby nerves or tissues.
Skull base
This type starts near the base of the skull, often behind the nose and close to the brainstem and important nerves. Many people notice headaches, double vision, facial numbness, trouble swallowing, or hearing changes rather than back pain. Because the tumor is in a tight space, even a small growth can cause symptoms.
Spinal
This type grows in the bones of the spine between the skull base and the tailbone. People with spinal notochordal cancer often have ongoing neck or back pain, and some may develop numbness, weakness, or trouble walking if the spinal cord or nearby nerves are compressed. Symptoms can build slowly, so it may first feel like a stubborn muscle or disc problem.
Sacral
This type begins in the sacrum, the triangular bone at the bottom of the spine just above the tailbone. Pain in the lower back, buttocks, or tailbone area is common, and some people also develop constipation, bladder changes, sexual dysfunction, or leg numbness as nearby nerves are affected. This is one of the more common types of notochordal cancer in adults.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in notochordal cancer, a rare cancer sometimes called chordoma. Unlike some more common illnesses, it has not been clearly linked to factors like diet, exercise, sleep, or other everyday habits, and there are no well-established screening tests or preventive medicines for people who do not have symptoms. Research is ongoing, and while healthy habits still matter for overall well-being, they have not been shown to reliably lower the risk of this cancer or prevent symptoms from starting.
What genetics can tell you about symptoms
Genetics can sometimes help explain why notochordal cancer, often called chordoma, behaves differently from one person to another, but it usually cannot predict every symptom with certainty. In some people, inherited or tumor-related genetic changes may be linked to where the tumor forms, how fast it grows, and whether symptoms such as pain, headaches, nerve problems, or trouble with bowel or bladder control start earlier or become more severe. Even so, symptoms are shaped just as much by the tumor’s size and location, so genetics is only one part of the picture.
Causes and risk factors
Most notochordal cancer cases, also called chordoma, appear to begin in tiny remnants of the notochord, a structure present before birth. Rare inherited gene changes, especially involving TBXT, can raise the chance of notochordal cancer, but family history is uncommon. This cancer is seen more often in adults and is slightly more common in men. That said, risk is only part of the story. Researchers have not found strong links with smoking, diet, injury, or most environmental exposures, so many people with notochordal cancer have no clear cause.
What are the most common causes or risk factors?
The exact cause of notochordal cancer is usually not known, but it is thought to begin in small leftover cells from early development that stay near the spine or base of the skull after birth. The clearest risk factors are a rare family history of this cancer and certain inherited gene changes, especially in a gene called T, which helps the spine form before birth. It is also seen more often in adults, especially men, and there is no strong evidence that common lifestyle factors like diet, smoking, or a past injury are major causes.
Environmental and biological risk factors
The known risk factors for notochordal cancer are limited, partly because this tumor is so rare. Awareness of both biological and environmental influences helps you feel prepared. So far, the clearest patterns are biological, while proven environmental triggers have not been confirmed.
Notochordal cancer is diagnosed most often in adults, especially from middle age onward. The overall risk is still very low, but age is one of the clearest biological patterns doctors see.
Notochordal cancer is somewhat more common in males than in females. The reason is not fully understood, but sex-based biology appears to affect risk.
This cancer begins in small leftover cells from the notochord, a structure present early in fetal development. Most people with these cell remnants never develop cancer, but they are the biologic source of the tumor.
These leftover cells are more likely to persist at the base of the skull, along the spine, and in the tailbone area. That helps explain why notochordal cancer usually starts in those parts of the body.
Genetic risk factors
For many people living with notochordal cancer, often called chordoma, one of the first questions is whether it could affect other relatives. Most cases do not seem to be inherited, but a small number are linked to gene changes passed through families. The strongest known inherited link involves TBXT, and rarer links involve SMARCB1 or inherited conditions such as tuberous sclerosis. Carrying a genetic change doesn't guarantee the condition will appear.
Family history: When doctors assess genetic risk factors for notochordal cancer, family history is one of the first things they ask about. Most families will not have another affected relative, but several cases in close relatives can suggest an inherited risk.
TBXT changes: Extra copies of TBXT are the clearest known inherited link to notochordal cancer. TBXT helps control early notochord cells, and too much activity from this gene can increase risk.
SMARCB1 changes: Changes in SMARCB1 are linked to a less common form of notochordal cancer, especially in children. These changes may be found only in the tumor or, more rarely, be present from birth and raise inherited risk.
Tuberous sclerosis: A small number of people with notochordal cancer, especially children, also have tuberous sclerosis. This inherited condition is caused by changes in TSC1 or TSC2 and can raise risk in rare cases.
Tumor-only changes: In many people, the key DNA changes are found only in the cancer cells and are not inherited. This means relatives usually do not share the same risk just because one family member developed notochordal cancer.
Lifestyle risk factors
Lifestyle habits do not cause notochordal cancer, but they can influence symptoms, recovery, and the risk of complications during treatment. When people ask how lifestyle affects notochordal cancer, the most important issues are treatment tolerance, pain, mobility, and overall physical resilience. Choices around smoking, activity, nutrition, alcohol, sleep, and daily body mechanics can all make a meaningful difference.
Smoking does not cause notochordal cancer, but it can reduce blood flow and impair wound healing after surgery. It may also worsen lung function and increase complications during radiation, anesthesia, and recovery.
Gentle, regular movement can help preserve strength, balance, and endurance in people whose tumor or treatment affects the spine, pelvis, or skull base. Too little activity can worsen deconditioning, stiffness, fatigue, and loss of function.
Poor intake, unintentional weight loss, or low protein can make it harder to recover from surgery and tolerate cancer treatment. Excess body weight may also increase strain on painful bones and joints and make mobility more difficult.
Heavy alcohol use can interfere with sleep, worsen fatigue, and raise the risk of falls in people with pain, weakness, or nerve symptoms. It can also interact with pain medicines and other treatments used during cancer care.
Risk prevention
For most people, notochordal cancer cannot be prevented in a clear, proven way. This rare cancer usually develops sporadically, and doctors have not identified everyday habits that reliably lower the chance of getting it. Prevention is about lowering risk, not eliminating it completely. In practice, the most useful steps are knowing whether your family history is unusual, getting persistent symptoms checked, and keeping follow-up appointments if a notochord-related lesion has already been found.
There is no established diet, supplement, or lifestyle change known to prevent notochordal cancer. Many living with this condition had no obvious warning signs or avoidable risk factors beforehand.
A small number of people may have an inherited risk, so an unusual family history of chordoma or related tumors is worth discussing with a doctor or genetic counselor. If risk seems higher, relatives may be offered personalized advice about monitoring.
Knowing the early symptoms of notochordal cancer can help people seek care sooner, especially for ongoing headaches, double vision, back pain, or bowel and bladder changes that do not improve. Early evaluation does not prevent the cancer from starting, but it can reduce harm by finding it before it causes more pressure on nearby nerves or the brainstem.
Symptoms from notochordal cancer often look like common problems at first, such as stubborn neck pain or sciatica-like pain that keeps coming back. If symptoms are persistent, worsening, or linked with numbness, weakness, or balance trouble, prompt medical review is important.
Can you prevent Notochordal cancer?
There is no known way to prevent notochordal cancer, because this rare cancer usually develops without a clear cause that people can control. For most people living with it, there are no proven lifestyle changes that can reliably stop it from happening. If it seems to run in a family, talking with a genetics specialist may help you understand risk and whether closer monitoring makes sense, but it cannot guarantee prevention.
Transmission
Notochordal cancer is not infectious, so it cannot be passed from one person to another through touch, kissing, sex, coughing, or sharing food. Many living with notochordal cancer are relieved to hear that being close to family, friends, or coworkers does not put anyone else at risk.
When people ask about how notochordal cancer is inherited, the answer is that most cases are not passed down in families and happen because of DNA changes that arise in cells over time. Rarely, an inherited gene change can raise the chance of developing this cancer, so if several relatives have had notochordal cancer or related tumors, a genetics specialist may help assess family risk.
When to test your genes
Most people do not need genetic testing for notochordal cancer because routine early-detection screening is not established. Testing is worth discussing if you have this cancer, several relatives with chordoma, or a family member diagnosed young. In those situations, inherited testing and tumor DNA testing may help clarify risk and guide treatment options or clinical trials.
Diagnosis
Notochordal cancer is often suspected after ongoing symptoms such as deep back or neck pain, headaches, double vision, numbness, or weakness start to interfere with daily life. Because these tumors can grow slowly, the diagnosis of notochordal cancer may take time and often begins with imaging after symptoms do not improve as expected. It’s natural to worry when symptoms don’t have a clear explanation.
Doctors ask about symptoms, how long they have been going on, and whether pain, weakness, or balance problems are getting worse. They also look at where symptoms are happening, since tumor location often guides the next tests.
A focused exam checks strength, sensation, reflexes, walking, and sometimes vision, hearing, or swallowing. These findings can show whether the tumor may be pressing on nearby nerves, the brainstem, or the spinal cord.
MRI is usually the main imaging test because it shows the tumor and nearby soft tissues in detail. It helps doctors see the size of the mass and whether it is affecting nerves, the spinal cord, or structures at the base of the skull.
CT shows bone changes more clearly than MRI and can reveal damage to the skull base, spine, or sacrum. It is often used alongside MRI to give a fuller picture before treatment planning.
How is Notochordal cancer diagnosed?
Notochordal cancer is usually diagnosed after imaging tests, most often an MRI and sometimes a CT scan, show a growth in the base of the skull or along the spine. Doctors usually need a small tissue sample, called a biopsy, to confirm the diagnosis by looking at the cells under a microscope and doing a few lab tests on the sample. Genetic testing is not the main way this cancer is diagnosed, but in some cases extra testing on the tumor may help confirm exactly what it is.
Stages of Notochordal cancer
Notochordal cancer does not have defined progression stages. This is because it is usually described by where the tumor is, how large it is, whether it is pressing on nearby nerves or tissues, and whether it has spread, rather than by a set step-by-step pattern over time. Doctors usually start with a conversation about symptoms such as ongoing back, neck, or head pain, numbness, weakness, or changes in bowel or bladder control, since early symptoms of notochordal cancer can look like more common problems at first. Diagnosis and follow-up usually involve imaging tests such as MRI or CT scans, and a biopsy is often needed to confirm the diagnosis.
Outlook and prognosis
Outlook for notochordal cancer varies mainly by tumor location, size, whether it can be completely removed, and whether it has already spread, with skull base and sacral tumors often behaving differently. Even though these tumors usually grow slowly, they are locally aggressive and have a high risk of coming back after treatment, so long-term follow-up is essential. The best outcomes are generally seen when surgeons can achieve complete resection and this is combined with specialized radiation therapy, while incomplete removal or metastatic disease worsens prognosis. Reported survival differs across studies and treatment centers, but 5-year overall survival is often around 50% to 80%, with lower long-term survival because of repeated local recurrence and treatment-resistant disease. Mortality is usually related to progressive local tumor growth affecting critical structures, complications of recurrence, or less commonly distant metastases, most often to the lungs, bone, or liver. Because prognosis depends heavily on expert multidisciplinary care, people treated at experienced chordoma centers may have better chances of prolonged disease control.
Long-term effects
Notochordal cancer can have lasting effects because it often grows near the brain, spine, and major nerves, and treatment itself can also leave ongoing changes. For many, this can mean a mix of cancer-related problems and long-term effects after surgery or radiation, sometimes lasting for years. The long-term picture is often shaped by where the tumor started, whether it comes back, and which nearby structures were affected. Even when the cancer is controlled, some people live with chronic symptoms that affect movement, comfort, and daily routines.
Ongoing pain is one of the most common long-term effects of notochordal cancer. It may come from pressure on nerves or bones, scar tissue after treatment, or changes in the spine or skull base. For many, symptoms can rise and fall rather than staying the same every day.
Lasting numbness, tingling, weakness, or poor coordination can happen if nerves or the spinal cord were affected by the tumor or treatment. Some may find that walking, climbing stairs, or using their hands takes more effort over time.
Tumors lower in the spine can lead to long-term trouble with bladder control, bowel function, or sexual function. These changes may persist after treatment if nearby nerves were damaged or compressed for a long time.
When notochordal cancer is near the skull base, some people have lasting headaches, double vision, hearing changes, swallowing trouble, or facial numbness. The exact pattern depends on which nerves and tissues were involved.
How is it to live with Notochordal cancer?
Living with notochordal cancer can feel like carrying an illness that presses on the body from the inside out, because these tumors often grow near the spine or base of the skull and can affect pain, movement, balance, swallowing, vision, or bowel and bladder function depending on where they are. For many people, daily life becomes a mix of medical appointments, scans, surgery or radiation, symptom management, and adjusting routines around fatigue, pain, and limits in mobility or work. The impact often reaches family and friends too, since they may help with transportation, caregiving, communication with the medical team, and the emotional weight of living with a rare cancer. Even so, many living with notochordal cancer find that good rehabilitation, pain support, and coordinated specialist care can make day-to-day life more manageable and help preserve independence.
Treatment and drugs
Notochordal cancer is usually treated with a mix of surgery and carefully planned radiation, because these tumors often sit close to the brain, spine, or major nerves and can be hard to remove completely. For many people, treatment begins with small daily steps, such as imaging tests, appointments with a surgical team, and planning for recovery after an operation. If surgery is not possible, or if some of the tumor remains, high-dose radiation is often used to help control growth and ease symptoms like pain, weakness, or pressure-related problems. Standard chemotherapy usually does not work well for most people with notochordal cancer, so drug treatment may involve targeted medicines in selected cases or a clinical trial, especially when the cancer has spread or comes back. Because early symptoms of notochordal cancer can be vague and treatment depends on where the tumor is and how fast it is growing, care is usually led by a team with experience in these rare tumors.
Can you cure Notochordal cancer?
There is no guaranteed cure for notochordal cancer, but some people can be cured if the tumor is found early enough and can be fully removed, often with radiation treatment as well. For many living with this cancer, treatment is aimed at removing as much of it as possible, slowing its growth, easing symptoms, and helping prevent it from coming back. Because it often grows in hard-to-reach areas like the spine or base of the skull, long-term follow-up is usually needed.
Non-drug treatment
Day-to-day, notochordal cancer can affect movement, nerve function, pain, and basic activities like sitting, walking, or swallowing, so treatment often involves more than one type of care. The main non-drug treatments are surgery and carefully planned radiation, with added therapies to help people recover function and manage symptoms. Supportive therapies can make treatment more manageable and help protect quality of life during and after care.
Surgery is often the main treatment when the tumor can be removed safely. The goal is to take out as much of the notochordal cancer as possible while protecting nearby nerves, the spinal cord, or the brainstem.
High-dose radiation is commonly used after surgery or sometimes instead of surgery when an operation is not possible. For many, radiation therapy for notochordal cancer is planned very precisely because these tumors sit close to sensitive structures.
Proton therapy, stereotactic radiation, and other highly targeted methods may help deliver treatment while limiting damage to nearby healthy tissue. Not every approach works the same way, so the best choice depends on where the tumor is and whether it has come back.
Physical therapy and occupational therapy can help with strength, balance, walking, and daily tasks such as dressing or getting in and out of a chair. After treatment, some may find these therapies especially useful if the tumor or surgery affected the spine, pelvis, or nerves.
Your genes may have an impact on how drugs work for you
For people living with notochordal cancer, treatment is usually centered on surgery and radiation, so inherited gene differences are not yet a routine part of choosing medicines the way they are for some other cancers. In advanced cases, doctors may test the tumor itself to look for changes that could make a targeted drug more likely to help, but this is different from the gene changes you are born with, and the benefit can vary from person to person. In day-to-day care, this means most medication choices are still based more on the tumor’s location, how much it has grown, past treatments, and side effects than on a standard gene-based drug test.
Pharmacological treatments
Medicines are not usually the main treatment for notochordal cancer, which is often called chordoma. Surgery and radiation are used most often, while drugs may be considered when the cancer has spread, comes back, or cannot be fully removed. Not everyone responds to the same medication in the same way. For many, this can mean trying a targeted drug or immunotherapy based on where the tumor is growing, how fast it is changing, and what earlier treatments have or have not done.
Imatinib is one of the most commonly used targeted drugs for advanced chordoma, especially when the tumor shows signals that this pathway may be active. It may help slow growth more often than shrink the tumor a lot.
Erlotinib, lapatinib, and afatinib are targeted drugs that may be used for some people with notochordal cancer when tests suggest the EGFR pathway is involved. These medicines are usually considered in recurrent or metastatic disease rather than as first treatment.
Sorafenib, sunitinib, and pazopanib are targeted drugs that affect blood vessel growth feeding the tumor. In some people with chordoma, they may help keep the disease stable for a time.
Pembrolizumab or nivolumab may be offered in selected cases, especially for cancer that has spread or kept growing after other treatment. These drugs do not help everyone, but they are part of the growing options for advanced notochordal cancer treatment.
Genetic influences
If others in your family have faced notochordal cancer, it is reasonable to ask whether genes may be part of the story. In most people, notochordal cancer does not appear to be strongly inherited, but genetics can still influence risk. A small number of families have an inherited change in a gene called TBXT, which helps guide early development of the spine, and this can raise the chance of developing these tumors. Having a gene change doesn’t always mean you will develop the condition, and many living with notochordal cancer have no known family history. The tumor itself can also pick up DNA changes over time that are not passed down from parents, which may help explain why the cancer starts and grows. If there is a family history of notochordal cancer, or if it appears at a younger age than expected, genetic counseling and sometimes testing may help clarify risk for you and your relatives.
Is Notochordal cancer genetic?
Genetics matter mainly in the tumor itself, not as an inherited cause. Most notochordal cancer cases happen sporadically through DNA changes that develop over time, while inherited risk is rare.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with notochordal cancer, the biggest treatment decisions are not about one pill versus another but whether surgery, radiation, or both can control the tumor. Genetics can still matter: testing the tumor may show changes in certain genes or growth pathways that help doctors decide if a targeted drug or a clinical trial is worth considering, especially if notochordal cancer comes back or cannot be fully removed. In a small number of families, inherited genetic changes linked to notochordal cancer can also matter for counseling relatives, although most cases are not clearly inherited. Not every difference in response is genetic, but your overall health, other medicines, and the exact location of the tumor also shape which treatment is safest and most likely to help. For some people, genetic testing for notochordal cancer treatment may open access to newer medicines, but it does not replace standard care, which often centers on expert surgery and carefully planned radiation. If drug treatment is being considered, your care team may also review whether your own genes could affect side effects or dosing, although this kind of pharmacogenetic testing is not routine for everyone with notochordal cancer.
Interactions with other conditions
Notochordal cancer can affect more than the area where the tumor starts, especially when it grows near the brain, spine, or nerves, so day-to-day symptoms may overlap with other health problems. For example, someone may think worsening back pain or leg weakness is from arthritis or a slipped disk, when the cancer is also pressing on nearby tissues. If notochordal cancer is near the base of the skull, it can also interact with conditions that cause headaches, vision changes, swallowing trouble, or balance problems, which can make the picture harder to sort out. Having more than one diagnosis can make symptoms feel harder to untangle. Treatments for notochordal cancer, including surgery or radiation, may also affect nearby structures and can complicate recovery in people already living with nerve problems, mobility limits, or other serious illnesses. Because early symptoms of notochordal cancer can resemble more common spine or nerve conditions, it is important for doctors to look at the whole pattern of symptoms rather than assuming there is only one cause.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Notochordal cancer?
Because notochordal cancer often causes pain, nerve pressure, or headaches depending on where it grows, it can be mistaken for much more common problems such as a slipped disk, arthritis in the spine, sciatica, or a tailbone injury. When it grows near the base of the skull, it may also look like sinus problems, migraines, or other growths in that area, including noncancerous tumors. Other bone or spine tumors can cause similar symptoms too, so imaging tests are usually needed to tell them apart.
History
Throughout history, doctors came across unusual tumors growing near the base of the skull or along the spine, but for a long time they were not sure what they were seeing. Some people had years of headaches, double vision, trouble swallowing, or ongoing back pain before the cause became clear. What we now call notochordal cancer, often known medically as chordoma, was gradually recognized as its own condition rather than being grouped with other bone or cartilage tumors.
In the mid-1800s, early pathologists described strange tissue that seemed to come from tiny leftover cells from the notochord, a structure that helps form the spine very early in development. A few decades later, researchers gave these tumors the name chordoma and linked them more clearly to those embryonic remnants. That was an important step, because it explained why the cancer often appears in very specific places, especially the skull base and the lower spine.
At first, diagnosis was difficult. Before modern scans, many living with notochordal cancer were identified only after surgery or even after death, when the tissue could be examined under a microscope. These tumors can grow slowly, and early symptoms of notochordal cancer often look like more common problems, which is one reason the condition was historically missed or diagnosed late.
As medical science evolved, doctors became better at telling notochordal cancer apart from other tumors that can affect the same areas. Imaging tests such as CT and MRI changed the picture, making it easier to see where the tumor starts and how it presses on nearby nerves, the brainstem, or the spinal cord. Surgeons and radiation specialists also learned that treatment can be challenging because these tumors sit so close to delicate structures.
In recent decades, awareness has grown, and researchers later identified a genetic cause in some families and studied the biology of the tumor more closely. This has helped confirm that notochordal cancer is a distinct disease with its own behavior, even though it can vary from one person to another. Today, care is usually planned by teams with experience in rare bone and spine tumors, reflecting how much understanding has improved since those first puzzling case reports.